SCHEMBL6308562

SCHEMBL6308562

CN(C)Cc1ccc2cc(NC(=O)c3ccc(-c4ccc(Cl)cc4)nc3)ccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 12/20 0.58
HTR2C P28335 7/20 0.58
KCNH2 Q12809 2/20 0.51
TRPV1 Q8NER1 1/20 0.48
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
ABL1 P00519 1/20 0.47
F10 P00742 1/20 0.46
KLKB1 P03952 1/20 0.46
ROCK2 O75116 1/20 0.46
WNT1 P04628 1/20 0.44
CLK2 P49760 1/20 0.44
CLK3 P49761 1/20 0.44
GSK3B P49841 1/20 0.44
DYRK1A Q13627 1/20 0.44
P4HTM Q9NXG6 1/20 0.43
PTPN1 P18031 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6308300 0.91 MCHR1 (0.59) MCHR1HTR2CTRPV1NPC1RAB9A
SCHEMBL6305509 0.90 MCHR1 (0.58) MCHR1HTR2CKCNH2TRPV1ABL1
SCHEMBL2925130 0.89 MCHR1 (0.58) MCHR1HTR2CKCNH2TRPV1F10
SCHEMBL2929377 0.87 MCHR1 (0.60) MCHR1HTR2CMEN1NPC1RAB9A
SCHEMBL2923659 0.85 MCHR1 (0.56) MCHR1HTR2CKCNH2TRPV1MEN1
SCHEMBL6305345 0.83 MCHR1 (0.52) MCHR1HTR2CKCNH2MEN1NPC1
SCHEMBL2928407 0.83 MCHR1 (0.54) MCHR1MEN1NPC1RAB9AKMT2A
SCHEMBL2926180 0.82 MCHR1 (0.82) MCHR1HTR2CNPC1RAB9AF10
SCHEMBL2921113 0.81 MCHR1 (0.80) MCHR1HTR2CF10
SCHEMBL2923091 0.80 MCHR1 (0.61) MCHR1HTR2CTRPV1MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6930185-B2 Melanin-concentrating hormone antagonist TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-08-16 US disclosed
US-20040077628-A1 Melanin-concentrating hormone antagonist TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-04-22 US disclosed
EP-1285651-A1 MELANIN CONCENTRATING HORMONE ANTAGONISTS Takeda Chemical Industries, Ltd. (JP) 2003-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077628-A1 Melanin-concentrating hormone antagonist MCHR1, MC1R, MCHR2 MCHR1 1/4885HTR2C 107/4885KCNH2 2764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.